The Active Mind Trial: An Adaptive Randomized Trial to Improve Function and Delay Dementia

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age55-89
SponsorUniversity of Alabama at Birmingham

About this trial

Older adults at risk for dementia show a variety of cognitive deficits, which can be ameliorated by different cognitive training (CT) exercises. The best combination of CT exercises is unknown. The aim is to discover the most efficacious combination of CT exercises as compared to cognitive stimulation (which will serve as a stringent, active control) to modify the functional trajectories of older adults' with MCI, who are at high risk for dementia. The primary objective of the U01 phase was to design and pilot-test an adaptive, randomized clinical trial (RCT) of cognitive training (CT) combinations aimed to enhance performance of instrumental activities of daily living (IADL) among persons with mild cognitive impairment (MCI). In the R01 phase, the objective is to identify the best combination of CT exercises to delay dementia onset among persons with MCI. The longitudinal endpoint goal is reducing incident dementia. The primary aim of the study is to determine which CT combination has the best probability to delay dementia by producing the largest IADL improvements. The study further aims to explore neuroimaging and novel blood-based biomarkers.

Eligibility criteria

Qualifiers

55 to 89 years of age

Montreal Cognitive Assessment Score of 18-27 inclusive

History of some change in cognitive function relative to established baseline and either 1) a CDR of 0.5; or 2) CDR of 0 and a clinical diagnosis of mild cognitive impairment (MCI) based on a multidisciplinary evaluation that included standardized neuropsychological testing

If reports use of medications typically prescribed for dementia such as Namenda, Memantine, Namzaric, Donepezil, Aricept, Rivastigmine, Exelon, Razadyne, Galantamine, or Reminyl, dose has been stable for at least 30 days

Disqualifiers

Currently enrolled in another randomized clinical trial, treatment trial, or another research study that assesses cognition

Dementia diagnosis

Clinical Dementia Rating Scale of 1 or greater

History of large vessel stroke with significant residual motor or cognitive impairment

Trial design

Treatments tested in this trial

  • Cognitive Training
  • Computerized Cognitive Stimulation

Treatment groups

1,305 Participants
are divided into 5 treatment groups

Sponsors and collaborators

University of Alabama at Birmingham

Lead sponsor

University of Florida

Collaborator

University of Minnesota

Collaborator

National Institute on Aging (NIA)

Collaborator

Clemson University

Collaborator

University of California, San Francisco

Collaborator